Table of Contents

company-logo

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Scopus BioPharma Dividend Announcement

• Scopus BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Scopus BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Scopus BioPharma Dividend History

Scopus BioPharma Dividend Yield

Scopus BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Scopus BioPharma stock? Use our calculator to estimate your expected dividend yield:

Scopus BioPharma Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio-0.00
ROE911.69%
Payout ratio0.00%
Current ratio0.05
Quick ratio0.05
Cash Ratio0.02

Scopus BioPharma Dividend FAQ

Does Scopus BioPharma stock pay dividends?
Scopus BioPharma does not currently pay dividends to its shareholders.
Has Scopus BioPharma ever paid a dividend?
No, Scopus BioPharma has no a history of paying dividends to its shareholders. Scopus BioPharma is not known for its dividend payments.
Why doesn't Scopus BioPharma pay dividends?
There are several potential reasons why Scopus BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Scopus BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Scopus BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Scopus BioPharma a dividend aristocrat?
Scopus BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Scopus BioPharma a dividend king?
Scopus BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Scopus BioPharma a dividend stock?
No, Scopus BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Scopus BioPharma stocks?
To buy Scopus BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Scopus BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.